Our Clients
VitalSignum, Finland and Vendor Junction sign a development agreement for market entry in the Middle East, Africa, South Asia and LATAM markets. Vital Signum’s flagship device, Beat2phone is a simple, reliable and easy-to-use wearable electrocardiogram (ECG) sensor with a phone application connected to a cloud analytics service for fast, cost-effective screening of heart problems. Beat2Phone Point of Care (POC) ECG is an IoT and AI-based cardiac assessment medical device to screen and treat patients with cardiac abnormalities and palpitation symptoms in the basic healthcare units and primary healthcare centers instead of referring the patients to often unnecessarily, to the high-cost secondary care heart hospitals and specialists.
Beat2Phone ECG is CE certified and reliable and easy-to-use wearable electrocardiogram (ECG) sensor placed on the chest and connected to a smartphone app with a cloud analytics service for fast, cost-effective screening of heart abnormalities with Real-Time Functionalities and detailed algorithmic generated detailed ECG report for treatment (Medical CE category 2A). The device can be comfortably worn by the patient for short rest and Holter ECG. The whole service entity has been designed with AI-driven automation to save healthcare entities and professionals valuable time and costs with reliable ECG assessments and reports.
Beat2Phone ECG is an ideal diagnostic tool for private sector clinics, primary care clinicians, cardiologists, neurologists and elderly home care professionals. Beat2Phone ECG enables improved cardiac diagnostics at PoC, assessment and preventive monitoring and observation of cardiac symptoms leading to cost and time savings in health care and a healthier life for the patients.
Cardiovascular diseases are one of the leading causes of death in the world. Approximately 10% of the global population suffers from cardiac-related symptoms such as atrial fibrillation, 40% of strokes are caused by atrial fibrillation. It is estimated that the number of patients with atrial fibrillation will increase globally 250% by 2050. In developing countries, Beat2Phone is very well positioned to address the patients’ limited access to cardiac diagnostics centers, medical professionals, treatment and high costs.
For more information, please visit www.vitalsignum.com and www.vendorjunctiongroup.com
Market Infographics . Project Videos . Case Studies . Success Stories . Industry Reports .
Discover More